<DOC>
	<DOCNO>NCT01021995</DOCNO>
	<brief_summary>Extracts produce Echinacea purpurea traditionally use prevention acute treatment influenzal infection like common cold . The aim clinical study assess clinical safety efficacy treatment Echinacea comparison placebo . 750 healthy subject history equal 2 cold episode per year recruit October November 2009 treat either Echinacea placebo period 4 month . Throughout study period adverse event ( AEs ) adverse drug reaction ( AEs least possible causal relation treatment ) record . Common cold related symptom record daily diary .</brief_summary>
	<brief_title>Echinacea Safety Study</brief_title>
	<detailed_description />
	<criteria>On average 2 cold episode per year Age 18 year Good physical condition Signed informed consent Women without appropriate effective contraception Participation clinical trial 30 day prior trial Pregnant breast feed woman Subjects pre−existing cold symptom 24h inclusion Concurrent participation another clinical trial Intake antimicrobial and/or antiviral medication inclusion Alcohol and/or drug abuse , narcotic drug addiction trial ( 50 gr / 10 cigarette per day ) Psychiatric disorder may influence result trial , epilepsy , suicide attempt Planned surgical intervention trial . Serious chronic disease influence absorption , metabolism elimination investigational product , especially progressive systemic illness like tuberculosis , leukaemia , collagen disorder multiple sclerosis Known AIDS , HIV−infections autoimmune disease Known diabetes mellitus ( type 1 ) Corticosteroid−treated asthma Atopic allergic subject ( medicinal treatment ) Known allergy plant composite family ( Asteraceae )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Safety Echinacea comparison placebo</keyword>
</DOC>